Acadia Pharmaceuticals Inc.

ACAD·NASDAQ·$21.26Share Price as of 11/2·$4BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report10/23/26 8-KCurrent report09/24/26 8-KCurrent report09/11/26 8-KCurrent report08/04/26 8-KCurrent report05/29/26

Prospectuses and Registrations

S-8Registration of securities for employees06/10/26 S-3Shelf registration05/09/25 S-8Registration of securities for employees09/23/24 S-8 POSPost-effective amendment (S-8)08/20/24 S-8 POSPost-effective amendment (S-8)08/20/24

Proxies

DEF 14ADefinitive proxy04/24/26 DEF 14ADefinitive proxy04/25/25 DEF 14ADefinitive proxy04/26/24 DEF 14ADefinitive proxy05/01/23 DEFR14ADefinitive proxy (revised)05/13/22

Ownership

Form 4Insider transaction10/30/26 Form 4Insider transaction08/07/26 SC 13GBeneficial ownership08/07/26 144Proposed sale of securities08/05/26 Form 4Insider transaction07/31/26

Other

ARSAnnual report to shareholders04/24/26 EFFECTRequest for effectiveness05/23/25 CORRESPCorrespondence with the SEC05/21/25 UPLOADLetter from the SEC05/14/25 ARSAnnual report to shareholders04/25/25